{"id":1192,"date":"2017-11-06T11:30:42","date_gmt":"2017-11-06T11:30:42","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmjopen\/?p=1192"},"modified":"2017-11-06T11:30:42","modified_gmt":"2017-11-06T11:30:42","slug":"top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/","title":{"rendered":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults"},"content":{"rendered":"

 <\/p>\n

Four new entries, and two re-entries, made it into BMJ Open\u2019s top 10 most read articles in October. Climbing back into the top position is a longitudinal cohort study by Xie et al.<\/em>, which examines the association between Proton Pump Inhibitors and the risk of all-cause mortality.<\/p>\n

\"Public<\/a>
\nNew in at number five is a systematic review by Fickweiler et al.<\/em>, exploring whether physicians\u2019 interactions with pharmaceutical industry representatives impact on their attitude and prescribing habits. The researchers extracted and synthesised data from studies encompassing an assortment of study designs; they demonstrate that interactions with pharmaceutical industry representatives affect physicians\u2019 prescribing behaviour and may compromise their objectivity.<\/p>\n

At number six is a new entry by Ziai et al.<\/em> The researchers audited a selection of systematic reviews published in 2013 and examined the proportion that included unpublished data in the analysis and assessed for publication bias. The results demonstrate that 36% of systematic reviews did not search for unpublished data and that publication bias was present in 40% of the published systematic reviews that assessed for it.<\/p>\n

Dhalwani et al.<\/em> are new in at number eight. Using data from The English Longitudinal Study of Ageing the researchers examine the association between polypharmacy and falls in older adults. The rate of falls was found to be 21% higher in people with polypharmacy (five or more drugs) than those without. The final new entry for October is at number 9; Firmino-Machado et al.<\/em> report the protocol for an ongoing population-based randomised controlled trial to improve Cervical Cancer Screening Adherence.<\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Rank<\/strong><\/td>\nAuthor(s)<\/strong><\/td>\nTitle<\/strong><\/td>\n<\/tr>\n
1<\/td>\nXie et al. <\/em><\/td>\nRisk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans<\/a><\/td>\n<\/tr>\n
2<\/td>\nGraham et al.<\/em><\/td>\nWhat factors are associated with reporting lacking interest in sex and how do these vary by gender? Findings from the third British national survey of sexual attitudes and lifestyles<\/a><\/td>\n<\/tr>\n
3<\/td>\nMamluk et al.<\/em><\/td>\nLow alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently ‘safe levels of alcohol during pregnancy? A systematic review and meta-analyses<\/a><\/td>\n<\/tr>\n
4<\/td>\n\u00a0<\/em><\/p>\n

Diniz et al.<\/em><\/td>\n

Breast cancer mortality and associated factors in Sao Paulo State, Brazil: an ecological analysis<\/a><\/td>\n<\/tr>\n
5<\/td>\nFickweiler et al. <\/em><\/td>\nInteractions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians attitudes and prescribing habits: a systematic review<\/a><\/td>\n<\/tr>\n
6<\/td>\nZiai et al. <\/em><\/td>\nSearch for unpublished data by systematic reviewers: an audit<\/a><\/td>\n<\/tr>\n
7<\/td>\nKennedy et al. <\/em><\/td>\nCoffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis<\/a><\/td>\n<\/tr>\n
8<\/td>\nDhalwani et al. <\/em><\/td>\nAssociation between polypharmacy and falls in older adults: a longitudinal study from England<\/a><\/td>\n<\/tr>\n
9<\/td>\nFirmino-Machado et al. <\/em><\/td>\nStepwise strategy to improve Cervical Cancer Screening Adherence (SCAN-CC): automated text messages, phone calls and face-to-face interviews: protocol of a population-based randomised controlled trial<\/a><\/td>\n<\/tr>\n
10<\/td>\nNickel et al.<\/em><\/td>\nWords do matter: a systematic review on how different terminology for the same condition influences management preferences<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n


\nMost read figures are based on pdf downloads and full text views. Abstract views are excluded.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

  Four new entries, and two re-entries, made it into BMJ Open\u2019s top 10 most read articles in October. Climbing back into the top position is a longitudinal cohort study by Xie et al., which examines the association between Proton Pump Inhibitors and the risk of all-cause mortality. New in at number five is a […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":343,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2470,2471],"tags":[],"class_list":["post-1192","post","type-post","status-publish","format-standard","hentry","category-content","category-highly-accessed"],"yoast_head":"\nTop 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open\" \/>\n<meta property=\"og:description\" content=\"  Four new entries, and two re-entries, made it into BMJ Open\u2019s top 10 most read articles in October. Climbing back into the top position is a longitudinal cohort study by Xie et al., which examines the association between Proton Pump Inhibitors and the risk of all-cause mortality. New in at number five is a [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Open\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-06T11:30:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920-300x200.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults\",\"datePublished\":\"2017-11-06T11:30:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/\"},\"wordCount\":513,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/11\\\/headache-1540220_1920-300x200.jpg\",\"articleSection\":[\"Content\",\"Highly accessed\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/\",\"name\":\"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/11\\\/headache-1540220_1920-300x200.jpg\",\"datePublished\":\"2017-11-06T11:30:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/11\\\/headache-1540220_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/11\\\/headache-1540220_1920.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/2017\\\/11\\\/06\\\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\",\"name\":\"BMJ Open\",\"description\":\"The official blog BMJ Open; a place to discuss medical research and discover the Editor's monthly top picks.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#organization\",\"name\":\"BMJ Open\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/10\\\/blog-logo-bmjopen.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/files\\\/2017\\\/10\\\/blog-logo-bmjopen.png\",\"width\":183,\"height\":34,\"caption\":\"BMJ Open\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjopen\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/","og_locale":"en_US","og_type":"article","og_title":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open","og_description":"  Four new entries, and two re-entries, made it into BMJ Open\u2019s top 10 most read articles in October. Climbing back into the top position is a longitudinal cohort study by Xie et al., which examines the association between Proton Pump Inhibitors and the risk of all-cause mortality. New in at number five is a [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/","og_site_name":"BMJ Open","article_published_time":"2017-11-06T11:30:42+00:00","og_image":[{"url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920-300x200.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/"},"author":{"name":"","@id":""},"headline":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults","datePublished":"2017-11-06T11:30:42+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/"},"wordCount":513,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920-300x200.jpg","articleSection":["Content","Highly accessed"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/","url":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/","name":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults - BMJ Open","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920-300x200.jpg","datePublished":"2017-11-06T11:30:42+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/11\/headache-1540220_1920.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmjopen\/2017\/11\/06\/top-10-most-read-in-october-physician-pharmaceutical-industry-interactions-systematic-reviews-and-unpublished-data-and-polypharmacy-and-falls-in-older-adults\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmjopen\/"},{"@type":"ListItem","position":2,"name":"Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#website","url":"https:\/\/blogs.bmj.com\/bmjopen\/","name":"BMJ Open","description":"The official blog BMJ Open; a place to discuss medical research and discover the Editor's monthly top picks.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmjopen\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#organization","name":"BMJ Open","url":"https:\/\/blogs.bmj.com\/bmjopen\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/10\/blog-logo-bmjopen.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjopen\/files\/2017\/10\/blog-logo-bmjopen.png","width":183,"height":34,"caption":"BMJ Open"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjopen\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/bmjopen\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts\/1192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/users\/343"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/comments?post=1192"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/posts\/1192\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/media?parent=1192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/categories?post=1192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjopen\/wp-json\/wp\/v2\/tags?post=1192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}